Table 1

Details of study population and stratified by documented history of vasospastic angina (VSA)

Participants, no. (%)
AllWithout VSAWith VSA
Overall5 764 7705 761 309 (99.94)3461 (0.06)
Sex
 Male2 954 982 (51.26)2 953 757 (51.27)1225 (35.39)
 Female2 809 788 (48.74)2 807 552 (48.73)2236 (64.61)
Year of birth, median (IQR) [range]1974 (1955–1994)
[1932–2018]
1974 (1955–1994)
[1932–2018]
1946 (1941–1954)
[1932–1990]
Age at end of follow-up, median (IQR) [range]43 (24–62)
[0–86]
43 (24–62)
[0–86]
59 (53–66)
[21–85]
Age at Prinzmetal onset, median (IQR) [range]NANA59 (53–66)
[21–85]
Education
 Unknown or 1–9 years692 193 (12.01)691 197 (12.00)996 (28.78)
 10–11 years2 422 567 (42.02)2 420 999 (42.02)1568 (45.30)
 >11 years2 650 010 (45.97)2 649 113 (45.98)879 (25.92)
Source
 Hospital discharge registerNANA2218 (64.09)
 Outpatient registerNANA1243 (35.91)
Spouse
 HusbandNANA1199 (39.38)
 WifeNANA1846 (60.62)
Comorbidity
 Hypertension640 698 (11.11)638 405 (11.08)2293 (66.25)
 Hyperlipidaemia222 912 (3.87)221 306 (3.84)1606 (46.40)
 COPD108 472 (1.88)108 092 (1.88)380 (10.98)
 Obesity163 979 (2.84)163 688 (2.84)291 (8.41)
 Diabetes mellitus254 726 (4.42)253 996 (4.41)730 (21.09)
 Myocardial infarction117 747 (2.04)116 661 (2.02)1086 (31.38)
 Raynaud’s phenomenon4216 (0.07)4197 (0.07)19 (0.55)
 Migraine111 908 (1.94)111 731 (1.94)177 (5.11)
 Cluster headache (Horton syndrome)4765 (0.08)4759 (0.08)6 (0.17)
 Myocarditis8420 (0.15)8390 (0.15)30 (0.87)
 Malignancy520 725 (9.03)519 826 (9.02)899 (25.98)
 Oesophagal disease185 985 (3.23)185 427 (3.22)558 (16.12)
 Alcohol abuse178 405 (3.09)178 222 (3.09)183 (5.29)
 Cocaine abuse2294 (0.04)2292 (0.04)2 (0.06)
 Tobacco use93 406 (1.62)93 087 (1.62)319 (9.22)
  • COPD, chronic obstructive pulmonary disease.